CVS Health (TSX:CVS) FFO


TSX:CVS CVS Health Corp TSX:CVS
83 GF Score
Price C$24.90
GF Value C$18.54
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is CVS Health FFO?

FFO (Funds from operations) only applies to REITs.

TSX:CVS
83GF Score
CVS Health Corp TSX:CVS
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is CVS Health (TSX:CVS) Overvalued in 2026?

Based on GuruFocus' analysis, CVS Health stock appears to be overvalued. The current stock price of C$24.90 is trading 34.3% above its estimated GF Value™ of C$18.54. GuruFocus considers CVS Health to be Significantly Overvalued.

Key valuation signals for TSX:CVS:

  • FFO:
  • GF Value™: C$18.54 vs. price of C$24.90 (34.3% above fair value)
  • GF Score™: 83/100 with 10 warning signs

No single metric tells the full story. See the TSX:CVS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CVS Health Business Description

Address One CVS Drive, Woonsocket, RI, USA, 02895
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
83GF Score

Get the complete analysis for TSX:CVS

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$24.90
Price
C$18.54
GF Value